Tuvia Ben-Gal

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

D. Kitzman, V. Melenovský, D. Lewinski, 2024, The Lancet.

Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure.

D. Kitzman, S. Z. Abildstrom, B. Merkely, 2024, Journal of the American College of Cardiology.